Pharmaceutic preparation for treating respiratory tract infection

Abstract

The invention belongs to the field of traditional Chinese medicine preparations and particularly provides a pharmaceutic preparation for treating the respiratory tract infection. The pharmaceutic preparation is prepared from raw materials as follows: 25 parts of Chinese elder herbs, 18 parts of paper mulberry fruits, 22 parts of all-grass of pineleaf hedyotis, 25 parts of franchet groundcherry fruits, 25 parts of purslane herbs, 28 parts of largehead atractylodes rhizomes, 15 parts of fritillary, 15 parts of snakegourd fruits, 20 parts of peucedanum praeruptorum, 25 parts of mint, 20 parts of kudzuvine roots, 25 parts of twotoothed achyranthes roots, 20 parts of milkvetch roots, 15 parts of codonopsis pilosula, 15 parts of spine date seeds, 15 parts of dyers woad leaves, 25 parts of eucommia bark, 15 parts of mulberry leaves and 5 parts of liquorice roots. The pharmaceutic preparation can treat the respiratory tract infection.

Description

technical field [0001] The invention relates to the technical field of traditional Chinese medicine preparations, in particular to a medicinal preparation for treating respiratory infections, a preparation method and application thereof. Background technique [0002] Respiratory tract infection is divided into upper respiratory tract infection and lower respiratory tract infection. Upper respiratory tract infection refers to the general term of acute inflammation from the nasal cavity to the throat, and is the most common infectious disease. Lower respiratory tract infection is the most common infectious disease. During treatment, the pathogen causing the infection must be identified to select effective antibiotics. The existing drugs for the treatment of respiratory tract infection have the disadvantages of unstable curative effect, large side effects and high price. For this reason, it is urgent to develop more safe and effective drugs for the treatment of respiratory tra...

AI Technical Summary

Problems solved by technology

Lower respiratory tract infection is the most common infectious disease. During treatment, the pathogen causing the infection must be identified to select effective antibiotics. The existing drugs for the treatment of respiratory tract infection have the disadvantages of unstable curative effect, large side effects and high price.